Obesity Duration in Adult Women Affects Cancer Risk

Share this content:
The longer a woman is overweight, the higher her risk of several cancers.
The longer a woman is overweight, the higher her risk of several cancers.

(HealthDay News) -- The longer a woman is overweight, the higher her risk of several cancers, according to a study published in PLOS Medicine.

The new findings are based on data from the Women's Health Initiative. At the outset, researchers measured the women's current weight and height, and asked them to recall their weight at ages 18, 35, and 50. Over the next dozen years, 6,301 women developed a type of cancer that has been linked to obesity, such as breast, ovarian, endometrial, colon, kidney, liver, or pancreatic cancer.

The researchers found that the odds of obesity-related cancers rose by 7 percent for every 10 years a woman had been overweight. In particular, every 10-year increase in adulthood overweight duration was associated with a 5 and 17 percent increase in risk of postmenopausal breast and endometrial cancer, respectively. These figures rose to 8 and 37 percent, respectively, with adjustment for intensity of overweight.

RELATED: Higher Prevalence of Obesity in Cancer Survivors

"This study showed that a longer duration of overweight and obesity is associated with an increased risk of developing several forms of cancer," the authors write. "Furthermore, the degree of overweight experienced during adulthood seemed to play an important role in the risk of developing cancer, especially for endometrial cancer."

Reference

  1. Arnold M, Jiang L, Stefanick ML, et al. Duration of adulthood overweight, obesity, and cancer risk in the Women's Health Initiative: a longitudinal study from the United States. PLOS Medicine. 2016 Aug 16. doi: org/10.1371/journal.pmed.1002081 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters